KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Bristol Myers Squibb's Cash from Operations rose 1287.78% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 billion, marking a year-over-year increase of 1078.45%. This contributed to the annual value of $15.2 billion for FY2024, which is 959.6% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Cash from Operations is $6.3 billion, which was up 1287.78% from $3.9 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Cash from Operations high stood at $6.3 billion for Q3 2025, and its period low was $1.9 billion during Q2 2023.
  • Moreover, its 5-year median value for Cash from Operations was $3.8 billion (2022), whereas its average is $3.7 billion.
  • Examining YoY changes over the last 5 years, Bristol Myers Squibb's Cash from Operations showed a top increase of 13228.94% in 2021 and a maximum decrease of 3189.41% in 2021.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Cash from Operations stood at $4.1 billion in 2021, then dropped by 18.51% to $3.3 billion in 2022, then increased by 28.61% to $4.3 billion in 2023, then increased by 4.4% to $4.4 billion in 2024, then soared by 42.17% to $6.3 billion in 2025.
  • Its Cash from Operations stands at $6.3 billion for Q3 2025, versus $3.9 billion for Q2 2025 and $2.0 billion for Q1 2025.